These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2540907)
1. Corticotropin-releasing factor and vasopressin production in the rat pituitary tumor 7315a: biochemical and immunohistochemical studies. Morano MI; Estivariz FE Cancer Res; 1989 May; 49(10):2755-60. PubMed ID: 2540907 [TBL] [Abstract][Full Text] [Related]
2. Synergistical effects of ovine corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) on the release of pro-opiomelanocortin (POMC) related peptides by pituitary adenoma of a patient with Nelson's syndrome in vitro. Chan JS; Gaspar L; Iguchi H; Seidah NG; Ling N; Chrétien M Clin Invest Med; 1984; 7(4):205-8. PubMed ID: 6335868 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the expression and secretion of urocortin 2 in rat pituitary. Nemoto T; Iwasaki-Sekino A; Yamauchi N; Shibasaki T J Endocrinol; 2007 Feb; 192(2):443-52. PubMed ID: 17283244 [TBL] [Abstract][Full Text] [Related]
4. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a. Morano MI; Estivariz FE J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine alterations in nude mice with a human lung carcinoma producing pro-opiomelanocortin, corticotrophin-releasing hormone and arginine vasopressin. Morano MI; de Antueno RJ; Niedfeld G; Estivariz FE Clin Endocrinol (Oxf); 1990 Mar; 32(3):349-62. PubMed ID: 2160874 [TBL] [Abstract][Full Text] [Related]
6. Distributions of pro-vasopressin expressing and pro-vasopressin deficient CRH neurons in the paraventricular hypothalamic nucleus of colchicine-treated normal and adrenalectomized rats. Whitnall MH J Comp Neurol; 1988 Sep; 275(1):13-28. PubMed ID: 3262632 [TBL] [Abstract][Full Text] [Related]
7. Characterization of corticotropin releasing factor (CRF) and arginine vasopressin in median eminence extracts on sephadex gel-filtration. Hashimoto K; Ohno N; Yunoki S; Kageyama J; Aoki Y; Takahara J; Ofuji T Endocrinol Jpn; 1981 Feb; 28(1):1-7. PubMed ID: 6972867 [TBL] [Abstract][Full Text] [Related]
9. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres. Henry BA; Lightman SL; Lowry CA J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765 [TBL] [Abstract][Full Text] [Related]
10. Involvement of corticotropin-releasing factor and adrenocorticotropic hormone in the ovarian maturation, seawater acclimation, and induced spawning of Liza ramada. Mousa SA; Mousa MA Gen Comp Endocrinol; 2006 Apr; 146(2):167-79. PubMed ID: 16376890 [TBL] [Abstract][Full Text] [Related]
11. The role of corticotropin-releasing factor and vasopressin in hypoglycemia-induced proopiomelanocortin gene expression in the rat anterior pituitary gland. Suda T; Nakano Y; Tozawa F; Sumitomo T; Sato Y; Yamada M; Demura H Brain Res; 1992 May; 579(2):303-8. PubMed ID: 1628218 [TBL] [Abstract][Full Text] [Related]
12. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome. Gaspar L; Chan JS; Seidah NG; Chrétien M Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068 [TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Berkenbosch F; De Goeij DC; Tilders FJ Endocrinology; 1989 Jul; 125(1):28-34. PubMed ID: 2544403 [TBL] [Abstract][Full Text] [Related]
14. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536 [TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factors (CRF) secreted by the rat median eminence in vitro in the presence or absence of ascorbic acid: quantitative role of vasopressin and catecholamines. Bény JL; Baertschi AJ Endocrinology; 1981 Sep; 109(3):813-7. PubMed ID: 6266808 [TBL] [Abstract][Full Text] [Related]
16. Distribution and characterization of corticotropin-releasing factor and arginine vasopressin in rat hypothalamic nuclei. Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T Neuroendocrinology; 1982 Jan; 34(1):32-7. PubMed ID: 6977102 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor. Lamberts SW; Uitterlinden P; Bons EG; Verleun T Cancer Res; 1985 Mar; 45(3):1015-9. PubMed ID: 2982481 [TBL] [Abstract][Full Text] [Related]
19. Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal: correlation with hypothalamic noradrenergic activity and pituitary-adrenal response. Milanés MV; Laorden ML; Chapleur-Château M; Burlet A J Pharmacol Exp Ther; 1998 May; 285(2):700-6. PubMed ID: 9580616 [TBL] [Abstract][Full Text] [Related]
20. Ontogeny of corticotropin-releasing factor and of hypothalamic-pituitary-interrenal axis responsiveness to stress in tilapia (Oreochromis mossambicus; Teleostei). Pepels PP; Balm PH Gen Comp Endocrinol; 2004 Dec; 139(3):251-65. PubMed ID: 15560872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]